FDA Evaluating Vaccine GMP Requirements To Assess Impact on Supply
Executive Summary
FDA is re-evaluating its approach to good manufacturing practices, FDA Acting Commissioner Lester Crawford, PhD, suggested during a June 12 hearing on vaccine supply